Loading clinical trials...
Loading clinical trials...
Safety and IOP Lowering Efficacy of Low Dose Travoprost Ophthalmic Solutions Dosed BID Compared to TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions
Interventions
Travoprost ophthalmic solution, 0.0008%
Travoprost ophthalmic solution, 0.001%
+3 more
Locations
1
United States
Contact Alcon Call Center at 1-888-451-3937
Fort Worth, Texas, United States
Start Date
October 1, 2007
Primary Completion Date
January 1, 2008
Last Updated
December 6, 2012
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT06865144
NCT06689696
Lead Sponsor
Alcon Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions